{"id":106413,"date":"2020-05-02T16:44:59","date_gmt":"2020-05-02T23:44:59","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/05\/arthritis-drug-shows-significant-promise-in-severe-covid-19-cases-study"},"modified":"2020-05-02T16:44:59","modified_gmt":"2020-05-02T23:44:59","slug":"arthritis-drug-shows-significant-promise-in-severe-covid-19-cases-study","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/05\/arthritis-drug-shows-significant-promise-in-severe-covid-19-cases-study","title":{"rendered":"Arthritis drug shows \u2018significant\u2019 promise in severe COVID-19 cases: study"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/arthritis-drug-shows-significant-promise-in-severe-covid-19-cases-study.jpg\"><\/a><\/p>\n<p>The arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill COVID-19 patients, according to a French clinical study.<\/p>\n<p>The treatment, which suppresses the body\u2019s natural <a href=\"https:\/\/medicalxpress.com\/tags\/immune+response\/\" rel=\"tag\" class=\"\">immune response<\/a>, was found to reduce \u201csignificantly\u201d the number of deaths or life support interventions compared with a control group of patients.<\/p>\n<p>The study, carried out by the Paris university hospital trust (AP-HP), looked at 129 people hospitalised with moderate or severe viral pneumonia, which occurs in 5\u201310 percent of COVID-19 patients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill COVID-19 patients, according to a French clinical study. The treatment, which suppresses the body\u2019s natural immune response, was found to reduce \u201csignificantly\u201d the number of deaths or life support interventions compared with a control group of patients. The study, carried [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-106413","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/106413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=106413"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/106413\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=106413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=106413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=106413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}